Similar articles

• Very Late Reactivation of Retinopathy of Prematurity After Monotherapy With Intravitreal Bevacizumab.

  Snyder LL, Garcia-Gonzalez JM, Shapiro MJ, Blair MP. Snyder LL, et al. Ophthalmic Surg Lasers Imaging Retina. 2016 Mar;47(3):280-3. doi: 10.3928/23258160-20160229-12. Ophthalmic Surg Lasers Imaging Retina. 2016. PMID: 26985803
• Retinopathy of Prematurity: Intravitreal injections of bevacizumab: timing, technique, and outcomes.

  Mintz-Hittner HA. Mintz-Hittner HA. J AAPOS. 2016 Dec;20(6):478-480. doi: 10.1016/j.jaapos.2016.10.002. Epub 2016 Nov 2. J AAPOS. 2016. PMID: 27816750 No abstract available.
• Exudative retinopathy and detachment: a late reactivation of retinopathy of prematurity after intravitreal bevacizumab.

  Ittiara S, Blair MP, Shapiro MJ, Lichtenstein SJ. Ittiara S, et al. J AAPOS. 2013 Jun;17(3):323-5. doi: 10.1016/j.jaapos.2013.01.004. Epub 2013 Apr 19. J AAPOS. 2013. PMID: 23607977
• Intravitreal bevacizumab for retinopathy of prematurity: Considerations for informed consent.

  Mireskandari K, Collins ME, Tehrani N. Mireskandari K, et al. Can J Ophthalmol. 2015 Dec;50(6):409-12. doi: 10.1016/j.jcjo.2015.10.004. Can J Ophthalmol. 2015. PMID: 26651298 Review. No abstract available.
• [Retinopathy of prematurity - therapy. Part 2].

  Prepiaková Z, Tomčíková D, Kostolná B, Gerinec A. Prepiaková Z, et al. Cesk Slov Oftalmol. 2014 Apr;70(2):50-4. Cesk Slov Oftalmol. 2014. PMID: 25030312 Review. Czech.